Skip to Main Content
Raksha Jain, M.D.

Raksha Jain, M.D.

Medical Director, Adult Cystic Fibrosis Program

Professor

Endowed Title
Dedman Family Scholar in Clinical Care
School
Medical School
Department
Internal Medicine
Graduate Programs
Molecular Microbiology

You have reached the Academic Profile.

For more information on the doctor and patient care, please visit the clinical profile.

  • Biography

    Raksha Jain, M.D., M.S.C.I., is a Professor in the Department of Internal Medicine at UT Southwestern Medical Center and a member of its Division of Pulmonary and Critical Care Medicine. A Dedman Family Scholar in Clinical Care, she also serves as Medical Director of the Adult Cystic Fibrosis Program.

    Originally from Dallas, Dr. Jain holds a bachelor's degree in molecular biology from the Massachusetts Institute of Technology in Cambridge, Massachusetts. She received her medical degree from the University of Texas Houston Health Science Center and completed internal medicine residency training at UT Southwestern Medical Center, where she served as Chief Resident. She then obtained advanced training through a fellowship in pulmonary and critical care at Washington University School of Medicine in St. Louis, where she also earned a master's degree in clinical investigation.

    Certified in pulmonology, critical care medicine, and internal medicine, by the American Board of Internal Medicine, Dr. Jain joined the UT Southwestern faculty in 2010. 

    Dr. Jain's research interests include new treatments for cystic fibrosis and gender disparities in airway diseases. She oversees multicenter clinical trials related to cystic fibrosis and conducts her own clinical and molecular scientific research. She has earned awards from the National Institutes of Health, Children’s Medical Center of Dallas, and the Cystic Fibrosis Foundation for her work on hormonal influences of lung disease in cystic fibrosis.

    At UT Southwestern, Dr. Jain is a member of various committees, including the Ambulatory Clinic Medical Directors Committee, the Department of Medicine Clinical Trials Working Group, and the Aston Clinical Research Operations Working Group. She is also the Chair of the Department of Medicine Clinical Scholars Incentive Plan Committee. 

    Dr. Jain is active in several professional societies, including the American Thoracic Society, the American College of Chest Physicians, the Texas Medical Association, the Dallas County Medical Society, the Society of Women's Health Research, the American Medical Association, the Southern Society for Clinical Investigation, and the European Cystic Fibrosis Society.

    Outside of UT Southwestern, Dr. Jain is the Chair of the Sexual Health, Reproduction, and Gender Researching Working Group through the Cystic Fibrosis Foundation Therapeutics Development Network.

  • Education
    Medical School
    University of Texas Health Science Center at Houston (2001)
    Residency
    UT Southwestern Medical Center (2004), Internal Medicine
    Residency
    UT Southwestern Medical Center (2005), Internal Medicine
    Fellowship
    Washington University School of Medicine (2009), Pulmonary Diseases & Critical Care Medicine
    Graduate School
    Washington University School of Medicine (2010)
    Other Post Graduate Training
    Washington University School of Medicine (2010)
    Other Post Graduate Training
    Washington University School of Medicine (2010)
    Graduate School
    Washington University School of Medicine (2010), Clinical Investigation
  • Research Interest
    • Gender disparities in lung diseases
    • Sex hormone influence on host immunity
    • Treatment advances for Cystic Fibrosis
  • Publications
    Concentrations of dehydroepiandrosterone-sulphate (DHEA-S) in people with cystic fibrosis on and off elexacaftor-tezacaftor-ivacaftor
    Abid S, Shaffer L, Bayat A, Lee M, Keller A, Jain R Journal of Cystic Fibrosis 2024 Sep 23 874-877
    Prioritizing sexual and reproductive health research and care for people with cystic fibrosis: A 2023 workshop report from the Cystic Fibrosis Foundation Sexual Health, Reproduction, and Gender (SHARING) Research Working Group
    Kazmerski TM, Moy C, Aliaj E, Hudson J, Wright B, Poranski M, Sjoberg J, Taylor-Cousar JL, Georgiopoulos AM, Ladores SL, Trimble A, Tangpricha V, Khan FN, Ramasamy R, Leitner DV, West NE, Santos RD, Stransky OM, Wilson A, Keller A, Jain R Journal of Cystic Fibrosis 2024 Jul 23 639-646
    In vivo editing of lung stem cells for durable gene correction in mice
    Sun Y, Chatterjee S, Lian X, Traylor Z, Sattiraju SR, Xiao Y, Dilliard SA, Sung YC, Kim M, Lee SM, Moore S, Wang X, Zhang D, Wu S, Basak P, Wang J, Liu J, Mann RJ, LePage DF, Jiang W, Abid S, Hennig M, Martinez A, Wustman BA, Lockhart DJ, Jain R, Conlon RA, Drumm ML, Hodges CA, Siegwart DJ Science (New York, N.Y.) 2024 Jun 384 1196-1202
    Factors associated with pubertal growth outcomes in cystic fibrosis: Early Growth and Puberty in CF
    Patil R, Magaret AS, Jain R, Taylor-Cousar J, Hughan KS, Kazmerski TM Journal of Cystic Fibrosis 2024 May 23 538-544
    Clinician perspectives and practices related to sexual and reproductive care provision for males with cystic fibrosis
    Kazmerski TM, Stransky OM, Lavage DR, Hughan KS, Jain R, Ladores SL, Stalvey MS, Tangpricha V, Taylor-Cousar JL, West NE, Sawicki GS Journal of Cystic Fibrosis 2024 May 23 417-423
    The impact of switching to race-neutral reference equations on FEV1 percent predicted among people with cystic fibrosis
    Rosenfeld M, Cromwell EA, Schechter MS, Ren C, Flume PA, Szczesniak RD, Morgan WJ, Jain R Journal of Cystic Fibrosis 2024 May 23 443-449
    A provider survey assessing fetal impact of CFTR modulator use in males with CF during assisted and unassisted reproduction and partner pregnancy
    Taylor-Cousar JL, Janney R, Middleton PG, Jain R, Nightingale J, West NE, Shteinberg M, Velez D, Kazmerski TM Journal of Cystic Fibrosis 2024 May 23 412-416
    Sex differences in outcomes of people with cystic fibrosis treated with elexacaftor/tezacaftor/ivacaftor
    Wang A, Lee MJ, Keller A, Jian S, Lowe K, Finklea JD, Jain R Journal of Cystic Fibrosis 2024 Jan 23 91-98
    Glucagon-like-peptide-1 agonist therapy in adults with cystic fibrosis
    Park S, Jain R, Mirfakhraee S Journal of Cystic Fibrosis 2024
    Development of metabolic syndrome in people with Cystic Fibrosis one year after exposure to elexacaftor-tezacaftor-ivacaftor
    Ratti GA, Smith H, Mirfakhraee S, Reisch JS, Cohen LA, Jain R, Finklea JD Journal of Cystic Fibrosis 2024
  • Honors & Awards
    • CFF Foundation Harry Shwachman Clinical Research Award
      (2015-2018)
    • LEAD Capstone Dean's Recognition Award - U.T. Southwestern Medical Center
      (2015)
    • CREW award recipient
      (2010)
    • Dedman Family Scholar in Clinical Care
      (2010)
    • American Thoracic Society Career Development Award
      (2009)
    • Multidisciplinary Clinical Research Career Development Award
      (2009)
    • University of Texas Houston Health Science Center Gold Headed Cane Award
      Humanism in Medicine (2001)
  • Professional Associations/Affiliations
    • American College of Chest Physicians
    • American Thoracic Society
    • Association for Clinical and Translational Science (2009)
    • Dallas County Medical Society
    • Society for Women's Health Research (2012)
    • Texas Medical Association